Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jan 3;3(1):26-30.
doi: 10.21873/cdp.10175. eCollection 2023 Jan-Feb.

The Landscape of Single Nucleotide Polymorphisms in Papillary Thyroid Carcinoma

Affiliations
Review

The Landscape of Single Nucleotide Polymorphisms in Papillary Thyroid Carcinoma

Efthymios Kyrodimos et al. Cancer Diagn Progn. .

Abstract

Thyroid carcinoma represents a leading malignancy among those derived from human endocrine systems. It comprises a variety of different histological subtypes, including mainly papillary carcinoma, follicular carcinoma, anaplastic carcinoma, and medullar carcinoma. A broad spectrum of genetic imbalances, comprising gross chromosomal (polysomy/aneuploidy) and specific gene (mutations, amplifications, deletions) alterations, has been reported. Interestingly, the role of isolated, specific gene polymorphisms, especially of the single nucleotide polymorphism (SNP) type, in thyroid carcinoma is under investigation. SNPs are the most common genetic variations in the genome. The current molecular review focuses on the impact of specific SNPs on the biological behavior of papillary thyroid carcinoma in their carriers.

Keywords: DNA; Thyroid; carcinoma; gene; review; single nucleotide polymorphisms.

PubMed Disclaimer

Conflict of interest statement

The Authors have no conflicts of interest to declare.

References

    1. Wang Z, Luo J, Zhang Y, Xun P, Chen Z. Metformin and thyroid carcinoma incidence and prognosis: A systematic review and meta-analysis. PLoS One. 2022;17(7):e0271038. doi: 10.1371/journal.pone.0271038. - DOI - PMC - PubMed
    1. Graceffa G, Salamone G, Contino S, Saputo F, Corigliano A, Melfa G, Proclamà MP, Richiusa P, Mazzola S, Tutino R, Orlando G, Scerrino G. Risk factors for anaplastic thyroid carcinoma: a case series from a tertiary referral center for thyroid surgery and literature analysis. Front Oncol. 2022;12:948033. doi: 10.3389/fonc.2022.948033. - DOI - PMC - PubMed
    1. Canet M, Harbron R, Thierry-Chef I, Cardis E. Cancer effects of low to moderate doses of ionizing radiation in young people with cancer-predisposing conditions: a systematic review. Cancer Epidemiol Biomarkers Prev. 2022;31(10):1871–1889. doi: 10.1158/1055-9965.EPI-22-0393. - DOI - PMC - PubMed
    1. Zamora-Ros R, Cayssials V, Clèries R, Torrents M, Byrnes G, Weiderpass E, Sandström M, Almquist M, Boutron-Ruault MC, Tjønneland A, Kyrø C, Katzke VA, Le Cornet C, Masala G, Krogh V, Iannuzzo G, Tumino R, Milani L, Skeie G, Ubago-Guisado E, Amiano P, Chirlaque MD, Ardanaz E, Janzi S, Eriksson L, Freisling H, Heath AK, Rinaldi S, Agudo A. Sweetened beverages are associated with a higher risk of differentiated thyroid cancer in the EPIC cohort: a dietary pattern approach. Eur J Nutr. 2022 doi: 10.1007/s00394-022-02953-5. - DOI - PubMed
    1. Zamora-Ros R, Cayssials V, Franceschi S, Kyrø C, Weiderpass E, Hennings J, Sandström M, Tjønneland A, Olsen A, Overvad K, Boutron-Ruault MC, Truong T, Mancini FR, Katzke V, Kühn T, Boeing H, Trichopoulou A, Karakatsani A, Martimianaki G, Palli D, Krogh V, Panico S, Tumino R, Sacerdote C, Lasheras C, Rodríguez-Barranco M, Amiano P, Colorado-Yohar SM, Ardanaz E, Almquist M, Ericson U, Bueno-de-Mesquita HB, Vermeulen R, Schmidt JA, Byrnes G, Scalbert A, Agudo A, Rinaldi S. Polyphenol intake and differentiated thyroid cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Int J Cancer. 2020;146(7):1841–1850. doi: 10.1002/ijc.32589. - DOI - PubMed

LinkOut - more resources